IMCO and CAYMAN
2012.09.27

IMCO is pleased to announce its partnership with Cayman Chemicals, one of the leading companies that provides scientists worldwide with biochemical tools. The new joint venture will facilitate access to IMCO´s products in North America (U.S. and Canada) and worldwide.
Arne Holmgren, CEO of IMCO Corporation Ltd AB, commented, "we will share expertise and experience in tools for analysis of thioredoxin and glutaredoxin making this joint venture more competitive in the global market". Partnering with Cayman Chemicals is a strategic move to advance access to the global market".
A webcast of the announcement can be viewed at
http://www.caymanchem.com/
IMCO Corporation Ltd AB is today a major vendor of products needed in research on thioredoxins, thioredoxin reductases and glutaredoxins.


Cayman Chemical

Tillbaka...




New kit for high sensitivity GSH measurements

Measuring GSH in plasma and serum requires high sensitivity and is complicated by oxidation in samples upon storage. IMCO has developed a new kit for high sensitivity fluorescent determinations of GSH, GSSG and glutathionylated products.

Read more...

Mammalian thioredoxin reductases: TR-03 and TR-03B

Mammalian thioredoxin reductase 1 (TrxR) contain an essential seleocycteine residue encoded by the stop codon UGA. This makes recombinant expression in E.coli a challenge. IMCO now has preparations of rat TrxR with unsurpassed specific activity.

Read more...